Voyager Therapeutics
VYGR · NASDAQ
$2.19+$0.14 (+6.83%)TodayMarket closed ·
Prev close $2.05
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 24.8% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.4939 | -$0.40 | +19.0% |
| Q1 FY26 | -$0.5622 | -$0.47 | +16.4% |
| Q4 FY25 | -$0.5207 | -$0.46 | +11.7% |
| Q3 FY25 | -$0.5308 | -$0.47 | +11.5% |
| Q2 FY25 | -$0.5361 | -$0.57 | −6.3% |
| Q1 FY25 | -$0.458 | -$0.53 | −15.7% |
| Q4 FY24 | -$0.3737 | -$0.59 | −57.9% |
| Q3 FY24 | -$0.4628 | -$0.16 | +65.4% |
Earnings calls
- Wells Fargo 21st Annual Healthcare Conference
- Special Call - Voyager Therapeutics, Inc.
- Special Call - Voyager Therapeutics, Inc.
- 7th Annual HCW Neuro Perspectives Hybrid Conference
- Special Call - Voyager Therapeutics, Inc.
- Special Call - Voyager Therapeutics, Inc.
- Stifel 2026 Virtual CNS Forum
- Oppenheimer 36th Annual Healthcare Life Sciences Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.